Frequent phosphatidylinositol-3-kinase mutations in proliferative breast lesions
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Frequent phosphatidylinositol-3-kinase mutations in proliferative breast lesions
Authors
Keywords
-
Journal
MODERN PATHOLOGY
Volume 27, Issue 5, Pages 740-750
Publisher
Springer Nature
Online
2013-11-01
DOI
10.1038/modpathol.2013.197
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- PIK3CA-AKT pathway mutations in micropapillary breast carcinoma
- (2013) Ellen Flatley et al. HUMAN PATHOLOGY
- Novel Method for PIK3CA Mutation Analysis
- (2013) Daphne Ang et al. JOURNAL OF MOLECULAR DIAGNOSTICS
- Defining biomarkers to predict sensitivity to PI3K/Akt/mTOR pathway inhibitors in breast cancer
- (2012) A.M. Gonzalez-Angulo et al. CANCER TREATMENT REVIEWS
- The Life History of 21 Breast Cancers
- (2012) Serena Nik-Zainal et al. CELL
- Mucinous breast carcinomas lack PIK3CA and AKT1 mutations
- (2012) Elizabeth L. Kehr et al. HUMAN PATHOLOGY
- Phosphatidylinositol-3-kinase pathway mutations are common in breast columnar cell lesions
- (2012) Megan L Troxell et al. MODERN PATHOLOGY
- Sequence analysis of mutations and translocations across breast cancer subtypes
- (2012) Shantanu Banerji et al. NATURE
- Comprehensive molecular portraits of human breast tumours
- (2012) Daniel C. Koboldt et al. NATURE
- Conditional activation of Pik3ca H1047R in a knock-in mouse model promotes mammary tumorigenesis and emergence of mutations
- (2012) W Yuan et al. ONCOGENE
- Physiological Levels of Pik3caH1047R Mutation in the Mouse Mammary Gland Results in Ductal Hyperplasia and Formation of ERα-Positive Tumors
- (2012) Anjali Tikoo et al. PLoS One
- PIK3CA mutations rarely demonstrate genotypic intratumoral heterogeneity and are selected for in breast cancer progression
- (2011) Kevin Kalinsky et al. BREAST CANCER RESEARCH AND TREATMENT
- Multiplex Mutation Screening by Mass Spectrometry
- (2011) Carol Beadling et al. JOURNAL OF MOLECULAR DIAGNOSTICS
- Oncogenic PIK3CA-driven mammary tumors frequently recur via PI3K pathway–dependent and PI3K pathway–independent mechanisms
- (2011) Pixu Liu et al. NATURE MEDICINE
- PIK3CA Mutations in In situ and Invasive Breast Carcinomas
- (2010) A. Miron et al. CANCER RESEARCH
- Deciphering the Role of PI3K/Akt/mTOR Pathway in Breast Cancer Biology and Pathogenesis
- (2010) Priscilla F. McAuliffe et al. Clinical Breast Cancer
- PTEN mutation spectrum in breast cancers and breast hyperplasia
- (2010) JuLun Yang et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Gene Expression Profiling Reveals New Aspects of PIK3CA Mutation in ERalpha-Positive Breast Cancer: Major Implication of the Wnt Signaling Pathway
- (2010) Magdalena Cizkova et al. PLoS One
- PIK3CA mutations associated with gene signature of low mTORC1 signaling and better outcomes in estrogen receptor-positive breast cancer
- (2010) S. Loi et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Phosphatidylinositol-3-kinase and AKT1 mutations occur early in breast carcinoma
- (2009) Jennifer Dunlap et al. BREAST CANCER RESEARCH AND TREATMENT
- Expression of the K303R Estrogen Receptor- Breast Cancer Mutation Induces Resistance to an Aromatase Inhibitor via Addiction to the PI3K/Akt Kinase Pathway
- (2009) I. Barone et al. CANCER RESEARCH
- PIK3CA Mutation Associates with Improved Outcome in Breast Cancer
- (2009) K. Kalinsky et al. CLINICAL CANCER RESEARCH
- PIK3CA mutations mostly begin to develop in ductal carcinoma of the breast
- (2009) Hua Li et al. EXPERIMENTAL AND MOLECULAR PATHOLOGY
- High prevalence of PIK3CA/AKT pathway mutations in papillary neoplasms of the breast
- (2009) Megan L Troxell et al. MODERN PATHOLOGY
- An Integrative Genomic and Proteomic Analysis of PIK3CA, PTEN, and AKT Mutations in Breast Cancer
- (2008) K. Stemke-Hale et al. CANCER RESEARCH
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search